Enhanced functional recombinant factor VII production by HEK 293 cells stably transfected with VKORC1 where the gamma-carboxylase inhibitor calumenin is stably suppressed by shRNA transfection
- 31 December 2008
- journal article
- Published by Elsevier in Thrombosis Research
- Vol. 122 (3) , 405-410
- https://doi.org/10.1016/j.thromres.2007.11.002
Abstract
No abstract availableKeywords
This publication has 16 references indexed in Scilit:
- siRNA silencing of calumenin enhances functional factor IX productionBlood, 2006
- Management of SepsisNew England Journal of Medicine, 2006
- r-VKORC1 Expression in Factor IX BHK Cells Increases the Extent of Factor IX Carboxylation but Is Limited by Saturation of Another Carboxylation Component or by a Shift in the Rate-Limiting StepBiochemistry, 2006
- Mechanism of Action of Recombinant Activated Factor VII: An UpdateSeminars in Hematology, 2006
- Increased Production of Functional Recombinant Human Clotting Factor IX by Baby Hamster Kidney Cells Engineered to Overexpress VKORC1, the Vitamin K 2,3-Epoxide-reducing Enzyme of the Vitamin K CycleJournal of Biological Chemistry, 2005
- Engineering of a Recombinant Vitamin K-dependent γ-Carboxylation System with Enhanced γ-Carboxyglutamic Acid Forming CapacityJournal of Biological Chemistry, 2005
- New high‐technology products for the treatment of haemophiliaHaemophilia, 2004
- Warfarin and the Vitamin K-Dependent γ-Carboxylation SystemTrends in Molecular Medicine, 2004
- The Inhibitory Effect of Calumenin on the Vitamin K-dependent γ-Carboxylation SystemJournal of Biological Chemistry, 2004
- Vitamin K-dependent carboxylation and vitamin K metabolism in liver. Effects of warfarin.Journal of Clinical Investigation, 1985